Research Interest: Effects of different diets, Dietary factors and fatty acids (especially conjugated fatty acids) on health, Especially on the Cancer Risk.

Research Interest: Drug Metaboilism, Mass spectrometry, Pharmacokinetics and Pharmacodynamics, Medicine, Pharmacy.

Research Interest: Ophthalmology, Cataract Surger,Cornea, Refractive Eye Surgery, Keratoconus.

Research Interest: Liposomes, Drug Nanoparticles, Solid Lipid Nanoparticles and Lipid Based Drug Delivery Systems.

Research Interest: Medicinal Plants, Obtaining, Characterization and standardization of extracts, Testing their pharmacological Action, Testing antioxidant activity in vitro and in vivo, Analysis and  isolation of biologically active compounds (polyphenols, carotenoides, essential oils, terpenes, alkaloids), spectrometric and chromatographical analysis (HPLC, GC).

Research Interest: G-protein coupled receptors for lipid mediators, Molecular and cellular functions of lipid mediators.

Research Interest: Microbiology and Immunology, Antibiotic mechanism of Action and resistance, Inflammation and Natural Antiinflamatory Products.

Research Interest: Targeting drug delivery systems (TDDS), Multifunctional nanocarriers or macromolecules have many advantages for diseases treatments. Our lab employs diverse targeting delivery systems including conjugate, liposomes and micelles to deliver anticancer drug or gene for tumor therapy. In this process, we unitize stimuli-responsive strategies (e.g. enzyme-responsive) to obtain the targeting therapy of tumor. Cell-penetrating peptides (CPPs) are also adopted to cross cellular barriers. Internalization mechinisms of CPPs or CPP-cargoes are also focused by us.

Research Interest: Therapeutic relevance of plant-derived compounds in the field of the gastrointestinal pathologies (IBD, cancer, etc.) and on the signal transduction mechanisms involved in their action.Moreover, Toxicological aspects of natural products are also studied.

Research Interest: Drug utilisation, Public Health, Cardiology, Diabetology.

Research Interest: Pharmacology & Toxicology, Experimental Pharmacology, Toxicology.

Mehraliyeva Sevil Jabrayil graduated from the Faculty of Pharmacy of Azerbaijan State Medical Institute named after N.Narimanov in 1989 with honors diploma. was elected to the position and is currently working in this position.

 In 2010, S.J.Mehraliyeva defended her dissertation on the topic "Development of the technology for obtaining medicinal forms from some multicomponent plant assemblies and studying their biopharmaceutical properties", in 2011 she received the diploma of Doctor of Philosophy in Pharmacy, and in 2014 she received the scientific title of associate professor.

 Sevil Mehraliyeva is a member of the "Problem Commission on Pharmacy and Chemistry", 224156-Specialized Council for master's defense in "Pharmaceutical technology". He participated in the congresses held in 2020-2022, including training on Good Clinical Practice and received a certificate. In February 2022, he completed an internship at DAYTAM, Atatürk University of the Republic of Turkey.

Sevil Mehraliyeva made oral presentations at conferences held in the Republics of Azerbaijan, Russia, and Turkey during the period of her scientific research and was awarded certificates.

For the first time, Sevil Mehraliyeva developed immunotropic granules based on various phytocompositions, dental gel with anti-aging effect, anti-aging cream, anti-seborrheic shampoo, microcapsules for the treatment of atherosclerosis, anti-acne niosomal gel technology, and was awarded Azerbaijan and Eurasian patents (2017). -2022).

Since 2020, Mehraliyeva Sevil Jabrail has been working on her doctoral dissertation on the topic "Development of technology for obtaining nano-forms of medicine based on raw materials of natural origin".

According to the subject of his doctoral dissertation, he developed the technology of extraction from deer antlers grown in Azerbaijan for the first time. The technology of obtaining nanocapsules for the treatment of Alzheimer's, nanoemulsion and nanogel for the treatment of osteoporosis on the basis of this extract and the acquisition of an Azerbaijani patent in this field belong to Sevil Mehraliyeva (2021-2024).

In 2023-24, Sevil Mehraliyeva carried out the method of separating the actinide enzyme, which accelerates the digestion process, from the Chinese actinidia fruits grown in Azerbaijan and the microencapsulation of this enzyme.

Sevil Mehraliyeva also performed the technology of separating rutin from Japanese sophora buds and hop cones and preparing phytosomes based on rutin. Based on these phytosomes, the preparation of phytosomal gel with an effective effect in the treatment of periodontitis and the study of quality criteria were performed by Sevil Mehraliyeva (2024).

Research Interests: pharmaceutical technology, phyto- and animal medicinal technology, nanotechnology, nanocosmetology, nano- and micropharmaceutical medicinals, biopolymer technology, new drug delivery systems, including stomatological drug delivery systems.

Research Interest: Biomaterials, Nanomedicine, Pharmaceutical Nanotechnology, Nanovaccines, Targeted drug delivery, Nanotoxicity, surface biofunctionalization, Cell-nanoparticle Interactions.

Research Interest: Epidemiology, Health Management and Rheumatology.

Research Interest: Cancer Diagnostics, Cancer Research, Clinical Trials, Ophthalmology, Business, Economic Genetics, Stem Cell Biology, Cell Biology, Translational Cancer Research, Business Ethics, Oncology, Molecular Biology.